Bone morphogenetic proteins in cranial reconstructions: Clinical evaluation of heparin-chitosan as a carrier for bmp-2

Plastic and Reconstructive Surgery

Volumn 123, Issue 6, 2009, Pages

  Docherty Skogh, Ann Charlott ^a   Engstrand, Thomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM PHOSPHATE; CHITOSAN; HEPARIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TITANIUM; BIOMATERIAL; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; FIBRINOLYTIC AGENT;

BRAIN ARTERY ANEURYSM; BRAIN TUMOR; CALCIFICATION; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CRANIECTOMY; FREEZING; HUMAN; LETTER; NEUROIMAGING; POSTOPERATIVE INFECTION; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; SKULL DEFECT; SKULL SURGERY; SURGICAL APPROACH; SURGICAL SPONGE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; CASE REPORT; FRONTAL BONE; METABOLISM; METHODOLOGY; NOTE; PLASTIC SURGERY; SURGICAL EQUIPMENT; TEMPORAL BONE;

BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; FIBRINOLYTIC AGENTS; FRONTAL BONE; HEPARIN; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL MESH; TEMPORAL BONE;

EID: 67649391093     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181a66f52     Document Type: Letter

References (1)

1. Engstrand T, Veltheim R, Arnander C, et al. A novel biodegradable delivery system for bone morphogenetic protein-2. Plast Reconstr Surg. 2008;121:1920-1928.